KROUZON
Restoring Normal Child Development Without Lifelong Surgeries
About Krouzon
Krouzon Pharmaceuticals was founded by Dr. V.P. Eswarakumar, a then Associate Professor at Yale University, after 25+ years of hands-on research experience. He created the world’s first disease model for Crouzon and Pfeiffer syndromes and discovered treatment methods.
At Krouzon
Krouzon is developing therapeutics for children born with FGFR2-related Craniosynostosis Syndromes
Meet The Team
-
Jacob Eswarakumar, Ph.D.
Founder, Chair and Chief Scientific Advisor
Dr. Eswarakumar, a former Associate Professor at Yale University School of Medicine, founded Krouzon after 25+ years of hands-on research experience.
-
Research & Development Team
The R&D Team comprises Ph.D. level Scientists with 150+ combined years of experience.
-
Management Team
Krouzon Pharmaceuticals is a privately held Delaware C-Corporation managed and advised by passionate professionals.